RxDoctor Payments Data

Julie Washko

Family · Old Forge, PANPI 1639828460

Payments from drug & device makers

$11,846in general payments, 2019–2025

Across 734 payments — averaging $16.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Novo Nordisk$1K
  • Bayer$849
  • Pfizer$833
  • AstraZeneca$697
  • GSK$578
  • plus $6K from 43 others

What the payments were for

  • Food & beverage$11,846100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,846 in reported general payments places this provider in the 95th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$42,464
Medicare patients
328
Services billed
444

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban18$17,597
Trelegy ElliptaFluticasone/Umeclidin/Vilanter27$16,398
Albuterol Sulfate HfaAlbuterol Sulfate44$945
Levothyroxine Sodium46$559
Alprazolam51$545
Ezetimibe18$466
Rosuvastatin Calcium44$457
Losartan Potassium53$441
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav51$362
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen19$352
Trazodone Hcl16$303
Buspirone Hcl13$293
Lisinopril46$281
Tramadol Hcl18$271
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen11$263

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$17$17,59718 claims
GSKTrelegy Ellipta$578$16,39827 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,717 family providers in Pennsylvania.

Other family in Old Forge

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →